Unlocking the potential of <i>Pseudomonas aeruginosa</i> QS intermediates as antimicrobial synergists against three multidrug-resistant enteric bacteria. [PDF]
Kiran S +16 more
europepmc +1 more source
<i>Pseudomonas aeruginosa</i> Biofilms in Cystic Fibrosis: Interactions, Methods, and Therapeutic Strategies. [PDF]
Núñez-García LÁ +3 more
europepmc +1 more source
Purification, Characterization, and Oil-Displacement Performance of Rhamnolipid Biosurfactant Produced by <i>Bacillus</i> sp. DQ-4. [PDF]
Wei J +7 more
europepmc +1 more source
Enhanced rhamnolipid production in Pseudomonas aeruginosa 8D by systematic genetic engineering. [PDF]
Yuan L +11 more
europepmc +1 more source
Insights on the spatial distribution of the <i>Pseudomonas aeruginosa</i> secondary metabolites under swarming motility-inducing conditions using mass spectrometry imaging. [PDF]
Rosado-Rosa JM +3 more
europepmc +1 more source
A decade of insight into ExlA toxin research and the biotechnological potential of non-virulent <i>Pseudomonas aeruginosa</i> strains. [PDF]
García-Reyes S.
europepmc +1 more source
Role of cell-associated and secretion-independent virulence factors of Pseudomonas aeruginosa in microbial keratitis and anti-virulence therapeutic strategies. [PDF]
Akter T +6 more
europepmc +1 more source
Antiviral Activity of Rhamnolipids Nano-Micelles Against Rhinoviruses-In Silico Docking, Molecular Dynamic Analysis and In-Vitro Studies. [PDF]
Touabi L +4 more
europepmc +1 more source
Rhamnolipid from Pseudomonas sp. as a green surfactant for enhanced phytoremediation. [PDF]
Sorour A, Zobair N, Ghanem K, Khairy H.
europepmc +1 more source
<i>Pseudomonas aeruginosa</i> rhamnolipids stabilize human rhinovirus 14 virions. [PDF]
Baty JJ, Drozdick AK, Pfeiffer JK.
europepmc +1 more source

